News
Vibalogics boosts U.S. team with expert senior hires ahead of facility launch
Vibalogics, a global contract development and manufacturing organization (CDMO) specializing in the production of virotherapy products, has strengthened its North American team with new strategic hires, including a Chief Financial Officer (CFO), Vice President of Quality and Head of...
Drug Research
RDIF and Virchow Biotech partner for production of Sputnik V vaccine in India
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Virchow Biotech Private Limited (part of the Virchow Group), one of the leading vaccine and pharmaceutical producers in India, announce the agreement to produce in the country up...
Drug Research
Boston Pharmaceuticals Enters into Unique Multi-Year Out-License and Option Agreement with GSK
Boston Pharmaceuticals announced a pioneering three-year out-license and option agreement with GlaxoSmithKline PLC. Boston Pharmaceuticals will become a preferred GSK partner for select pre-phase 2 programs. This new agreement builds on the relationship established in 2018 with Boston Pharmaceuticals’...
News
CanSino’s Covid-19 vaccine receives approval in Hungary for emergency use
The Hungarian National Institute of Pharmacy and Nutrition has granted approval for the emergency use of Chinese company CanSino Biologics’ Covid-19 vaccine.
Named Convidecia, the vaccine is made upon an adenovirus-based viral vector vaccine technology platform and uses a single-dose...
Drug Research
US FDA approves Janssen’s PONVORY for relapsing multiple sclerosis
The US FDA has approved the Janssen Pharmaceutical Companies of Johnson & Johnson’s (JNJ) PONVORY (ponesimod) for treating adults with relapsing forms of multiple sclerosis (MS).
PONVORY is a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator. The approval will...
News
Fujifilm to Build the Largest Cell Culture Biopharmaceutical CDMO Facility in North America
FUJIFILM Corporation has announced the selection of Holly Springs, North Carolina as the location for its new large-scale cell culture production site in the United States. The previously announced investment of more than 200 Billion yen (2 Billion USD)...
News
Alcami Appoints Patrick D. Walsh as Chairman and Chief Executive Officer
Alcami, a global pharmaceutical contract development and manufacturing organization (CDMO), announced today that its Board of Directors has appointed Patrick D. Walsh as Chairman and Chief Executive Officer, effective immediately. He succeeds Walter J. Kaczmarek III, who is stepping...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read